Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,242.99
(
0.72%
)
News Focus
News Focus
Post# of 257624
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: investorgold2002 post# 120235

Wednesday, 05/18/2011 8:56:29 AM

Wednesday, May 18, 2011 8:56:29 AM

Post# of 257624

I believe they were 45% of the overall market when they were 70% of retail?

Generic Lovenox had a 44% share of dollar sales in 1Q11 (#msg-62519040).

Now you are saying they are 85% of retail in April?

That’s what IMS is reporting (#msg-63248831).

Wasn't retail 30% and GPO 70% of the total market?

Retail is approximately 30% of the US Lovenox market by prescription volume and approximately 40% by dollar sales (#msg-54355727).

“The notion that there’s a Chinese Wall between sell-side analysts
and investment bankers may be the second-biggest piece of BS
ever promulgated in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today